美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

三倍做多标普生物-Direxion

227.75

-3.2000-1.39%

盘前：229.001.25+0.55%04:30 EDT

成交量：43.34万

成交额：9,991.57万

市值：5.75亿

市盈率：- -

高：237.30

开：224.64

低：220.50

收：230.95

52周最高：341.93

52周最低：102.35

股本：252.45万

流通股本：252.45万

量比：0.87

换手率：17.17%

股息：0.91

股息率：0.40%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

FDA致函后，EVOLUS股价下跌高达10%。

特朗普：我们上任后发现，在狡诈的乔·拜登以及民主党执政时期，有近百万户通过奥巴马医改购买医疗保险的家庭被严重多收费用，

National Healthcare Properties宣布2026年第四季度普通股股息

美国 FDA 批准首款可随儿童身体生长的心脏瓣膜。

医疗健康板块综述：市场动态

医疗保健行业综述：市场观察

医疗保健板块综述：市场观察

医疗健康板块综述：市场观察

实时行情-TD Cowen表示，人工智能有望为医院带来利润提升

ADP报告：自5月以来，招聘活动首次加速，其中教育、医疗保健以及休闲和酒店行业引领增长。金融活动以及专业和商业服务行业则

罗氏（RHHBY）推出三合一新生儿遗传病筛查试剂盒多发性硬化症口服新药芬布替尼获FDA优先审评

亿帆医药：Ryzneuta增加中国境内生产场地获得美国FDA批准

港股异动 | 和黄医药(00013)涨超3% 宣布向FDA提交沃瑞沙®联合泰瑞沙®联合疗法的新药上市申请

健友股份：阿达木单抗40mg/0.4mL获FDA批准

艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准

美国食品药品监督管理局（FDA）批准艾伯维的JUVMO™（tavapadon）用于治疗帕金森病。

德展健康(000813.SZ)子公司创新药WYY026B注射液获得美国FDA新药临床试验批准

健友股份(603707.SH)子公司产品维生素B1注射液获得美国FDA批准

信达生物：IBI363临床研究获美国FDA批准新增非鳞状非小细胞肺癌研究人群

国家医保局局长章轲会见印度尼西亚国家健康保险首席执行官普约瓦斯基托

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/LABU/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":227.75,"timestamp":1791403200000,"preClose":230.95,"halted":0,"volume":433423,"hourTrading":{"tag":"盘前","latestPrice":229,"preClose":227.75,"latestTime":"04:30 EDT","volume":1297,"amount":291927.3333,"timestamp":1791448207503,"change":1.25,"changeRate":0.005488,"amplitude":0.021954},"delay":0,"changeRate":-0.013855812946525173,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"盘前交易","change":-3.2,"latestTime":"10-08 04:32:26 EDT","open":224.64,"high":237.3,"low":220.5,"amount":99915682.24985,"amplitude":0.072743,"askPrice":233.62,"askSize":100,"bidPrice":223.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":230.529,"aum":581967299.18,"dividendRate":0.004,"bidAskSpread":0.002401,"preHourTrading":{"tag":"盘前","latestPrice":229,"preClose":227.75,"latestTime":"04:30 EDT","volume":1297,"amount":291927.3333,"timestamp":1791448207503,"change":1.25,"changeRate":0.005488,"amplitude":0.021954},"postHourTrading":{"tag":"盘后","latestPrice":228.7,"preClose":227.75,"latestTime":"19:59 EDT","volume":2729,"amount":623483.6155,"timestamp":1791417573520,"change":0.95,"changeRate":0.004171,"amplitude":0.004911},"volumeRatio":0.8672265389706112,"impliedVol":0.9774,"impliedVolPercentile":0.748},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8672265389706112,"shares":2524486,"dividePrice":0.911,"high":237.3,"amplitude":0.072743,"preClose":230.95,"low":220.5,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":227.75,"committee":0.333333,"eps":0,"divideRate":0.004,"volume":433423,"delay":0,"ttmEps":0,"open":224.64,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":265.79,"twentyDayClose":279.02,"sixtyDayClose":274.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672534710","title":"FDA致函后，EVOLUS股价下跌高达10%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672534710","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672534710?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 22:24","pubTimestamp":1790951074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672795899","title":"特朗普： 我们上任后发现，在狡诈的乔·拜登以及民主党执政时期，有近百万户通过奥巴马医改购买医疗保险的家庭被严重多收费用，","url":"https://stock-news.laohu8.com/highlight/detail?id=2672795899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672795899?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 09:28","pubTimestamp":1790904509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","LABU","XLV","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141343649","title":"National Healthcare Properties宣布2026年第四季度普通股股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1141343649","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141343649?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 04:31","pubTimestamp":1790886665,"startTime":"0","endTime":"0","summary":"National Healthcare Properties, Inc.今日宣布，其董事会已批准派发每股普通股0.075美元的季度股息。该股息将以现金形式于2026年10月16日支付给截至2026年10月12日营业结束时登记在册的股东。National Healthcare Properties, Inc.是一家自我管理的房地产投资信托基金，专注于收购、持有并投资多元化的医疗保健房地产组合，重点是为美国不断增长的老年人口提供养老住房。最后，公司无义务更新或修订任何前瞻性声明，也无义务更新实际结果可能与任何前瞻性声明中预测结果存在差异的原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REET","BK4585","LABU","XBI","JJJ.SI","GLS.SI","CLR.SI","SRT.SI","SRU.SI","BK4588","NHP","CFA.SI","BK4581","XLV","BK4225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761903","title":"美国 FDA 批准首款可随儿童身体生长的心脏瓣膜。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761903?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 03:03","pubTimestamp":1790881422,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113616442","title":"医疗健康板块综述：市场动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1113616442","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113616442?lang=zh_cn&edition=fundamental","pubTime":"2026-10-02 00:28","pubTimestamp":1790872108,"startTime":"0","endTime":"0","summary":"市场动态最新汇总，聚焦医疗健康板块。赛诺菲股价上涨0.6%。Imricor Medical Systems自9月初进入ASX 300指数以来股价已下跌逾20%，Morgans的看多分析师认为，这为投资者创造了绝佳的买入机会。Imricor周三收于1.585澳元，此前8月曾触及2.07澳元的高点。Morgans认为，季节性疲软和利率上升可能是导致股价下跌的原因。近期消息面偏向积极。Morgans对Imricor给予投机性买入评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","XBI","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129884397","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1129884397","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129884397?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 16:24","pubTimestamp":1790843092,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察。分析师补充称，赛诺菲还需采取其他关键举措来填补该联盟重磅药物Dupixent专利在2031至2032年间到期后留下的销售缺口，包括潜在收购以及达成和解以推迟仿制版本的上市。赛诺菲股价上涨0.6%。阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","XBI","BK4581","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167055452","title":"医疗保健板块综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1167055452","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167055452?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 04:55","pubTimestamp":1790801739,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇编。阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。该警告信提醒其美国工厂存在监管机构所称的严重违规行为。Fresenius Kabi回应称未发现患者安全方面的问题。股价上涨1.4%至184.25澳元。IHH表示，在涉及第一三共及前Fortis发起人的纠纷中，其不受财务索赔约束。股价上涨0.1%至7.88林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182869669","title":"医疗健康板块综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1182869669","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182869669?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 00:24","pubTimestamp":1790785451,"startTime":"0","endTime":"0","summary":"阿斯利康正在一项晚期临床试验中测试其Datroway抗体药物偶联物与其PD-L1药物Imfinzi联合用于肺癌治疗。Fresenius Kabi回应称，未发现任何患者安全问题。2211 ET - 花旗分析师Megat Fais在一份报告中表示，IHH Healthcare近期的股价疲软很可能是一个增强的买入机会，与Fortis相关的诉讼担忧预计对运营影响有限。IHH表示，其不受涉及第一三共及前Fortis发起人的纠纷中的财务索赔约束。股价上涨0.1%至7.88林吉特。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4581","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671207596","title":"实时行情-TD Cowen表示，人工智能有望为医院带来利润提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2671207596","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671207596?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 21:18","pubTimestamp":1790774327,"startTime":"0","endTime":"0","summary":"TD Cowen表示，计费和收款是短期内最明显的机遇。TD Cowen表示，拥有强大数据和集中化运营的大型医疗系统有望率先受益。TD Cowen警告称，保险公司和政府项目最终可能会通过降低支付率来应对医院的成本节约，因此尽早采用该技术至关重要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4S45M15F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","LU2324357040.USD","SG9999014021.USD","BK4585","LU0211328371.USD","LU1267930490.SGD","THC","LU1489326972.SGD","LU1150488135.SGD","LU0130102774.USD","LU2244417387.USD","LU1150488218.USD","LU1261432733.SGD","LU1201861249.SGD","LU0130103400.USD","LU1201861165.SGD","LU0433182093.SGD","SG9999014005.SGD","XBI","SG9999014013.SGD","BK4581","LABU","LU0187121727.USD","SG9999014039.USD","LU0868494617.USD","IHF","LU0128525929.USD","LU0980610538.SGD","LU0310799852.SGD","LU0310800379.SGD","LU0203345920.USD","LU0648001328.SGD","LU1084165304.USD","UHS","IE00B3S45H60.SGD","LU0029864427.USD","LU0211327993.USD","LU0203347892.USD","LU1267930573.SGD","LU0882574055.USD","LU0648000940.SGD","XLV","HCA","LU0068578508.USD","IE00B775SV38.USD","BK4185","LU0708994859.HKD","BK4504","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671361204","title":"ADP报告：自5月以来，招聘活动首次加速，其中教育、医疗保健以及休闲和酒店行业引领增长。金融活动以及专业和商业服务行业则","url":"https://stock-news.laohu8.com/highlight/detail?id=2671361204","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671361204?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:21","pubTimestamp":1790770861,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["XLV","159940","BK4588","BK4581","LABU","VHT","CGVV","NOBL","BK4550","PEJ","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671272100","title":"罗氏（RHHBY）推出三合一新生儿遗传病筛查试剂盒 多发性硬化症口服新药芬布替尼获FDA优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2671272100","media":"金吾财讯","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671272100?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 16:45","pubTimestamp":1790757948,"startTime":"0","endTime":"0","summary":"金吾财讯 | 罗氏 宣布，其诊断业务旗下子公司TIB MOLBIOL正式在认可欧盟CE标志的国家推出LightMix Newborn TREC/SMN1/HBB基因检测试剂盒。该产品已获得体外诊断医疗器械法规认证，标志着罗氏在早期诊断与新生儿筛查领域的进一步拓展。此外，罗氏同时宣布，美国食品药品监督管理局已正式受理其在研药物芬布替尼的新药申请，并授予优先审评资格。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWM3M2E1ZjMzOTEwODk1MDE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306639","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","LABU","HRTS","BK4585","BK4007","RHHBY","CANC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671506275","title":"亿帆医药：Ryzneuta增加中国境内生产场地获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2671506275","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671506275?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 14:43","pubTimestamp":1790750631,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224170","title":"港股异动 | 和黄医药(00013)涨超3% 宣布向FDA提交沃瑞沙®联合泰瑞沙®联合疗法的新药上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224170","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224170?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:50","pubTimestamp":1790736612,"startTime":"0","endTime":"0","summary":"消息面上，9月29日，和黄医药发布公告，阿斯利康已向美国食品药品监督管理局提交沃瑞沙 和泰瑞沙 的联合疗法的新药上市申请，用于治疗接受一种表皮生长因子受体酪氨酸激酶抑制剂治疗期间或之后出现疾病进展的伴有MET过表达或扩增的局部晚期或转移性非小细胞肺癌患者。SAFFRON全球III期研究的数据支持了该项新药上市申请。据悉，沃瑞沙由阿斯利康与和黄医药共同开发，并由阿斯利康商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1191","00013","BK4588","BK4585","BK1587","IPOS","LABU","BK1588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671294611","title":"健友股份：阿达木单抗40mg/0.4mL获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2671294611","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671294611?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:01","pubTimestamp":1790668898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670578258","title":"艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670578258","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670578258?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 21:15","pubTimestamp":1790601343,"startTime":"0","endTime":"0","summary":"此次获批基于成功的3期TEMPO临床项目。艾伯维官方表示，计划于2026年10月正式将Juvmo投放美国市场，供帕金森病患者使用。据介绍，该药是艾伯维此前斥资87亿美元收购Cerevel Therapeutics公司后迎来的首个重大研发成果落地，进一步夯实了其在神经科学领域的全球领先地位。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306564","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","MEDX","VHT","LU1934455863.HKD","LU1720051017.SGD","BK4581","IYH","JDOC","FHLC","LU0124676726.USD","IE00BSNM7G36.USD","LU1929549753.HKD","TRUH","LABU","IXJ","LU0289961442.SGD","LU1718418525.SGD","PJP","PPH","LU0882574055.USD","IPOS","LU1934455277.USD","LU0128525929.USD","LU1839511570.USD","IBRN","LU0942090050.USD","LU0289739343.SGD","LU1267930573.SGD","LU1720051108.HKD","RXL","ABBV","BK4533","IE0009355771.USD","LU1989772923.USD","GLAM","FTXH","IE00B19Z3B42.SGD","LU1037948897.HKD","IE0002141913.USD","XLV","LU0203347892.USD","LU0211327993.USD","LU2087621335.USD","LU1496350502.SGD","LU0738911758.USD","LU1093756168.USD","AGNG","LU2125909247.SGD","LU1244550577.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670232662","title":"美国食品药品监督管理局（FDA）批准艾伯维的JUVMO™（tavapadon）用于治疗帕金森病。","url":"https://stock-news.laohu8.com/highlight/detail?id=2670232662","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670232662?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 20:04","pubTimestamp":1790597042,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159151","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670262238","title":"德展健康(000813.SZ)子公司创新药WYY026B注射液获得美国FDA新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670262238","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670262238?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 17:08","pubTimestamp":1790586484,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德展健康 发布公告，公司全资子公司北京红惠新医药科技有限公司于近日收到美国食品药品监督管理局通知，由红惠新申报的WYY026B注射液药品临床试验申请已获得美国FDA批准，开展相关临床研究。本次WYY026B注射液在美国的临床试验申请获批，是该款药品研发进程中的重要进展，将进一步提升公司在心脑血管药品研发领域的核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000813","159992","BK1161","IBBJ","BMED","BK1574","BK4585","IBBQ","LNGR","BK0114","06978","BK0239","MDTX","BK4588","LABU","MEDX","PSYK","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280512","title":"健友股份(603707.SH)子公司产品维生素B1注射液获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280512","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670280512?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 16:36","pubTimestamp":1790584569,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司香港健友实业有限公司(以下简称“香港健友”)于近日收到美国食品药品监督管理局(以下简称“美国FDA”)签发的维生素B1注射液200mg/2mL(100mg/mL)的ANDA批准通知(ANDA号：213131)。新批准产品进一步丰富了公司国际化的产品管线，强化公司国际市场布局。若后续推进美国市场上市销售，有望对公司经营业绩产生积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4588","LABU","BK0186","BK4585","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670284234","title":"信达生物：IBI363临床研究获美国FDA批准新增非鳞状非小细胞肺癌研究人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2670284234","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670284234?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 15:24","pubTimestamp":1790580265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670288191","title":"国家医保局局长章轲会见印度尼西亚国家健康保险首席执行官普约瓦斯基托","url":"https://stock-news.laohu8.com/highlight/detail?id=2670288191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670288191?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 10:52","pubTimestamp":1790563959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","LABU","BK4588","XLV","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}